PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | C0267373|intestinal bleeding |
| Sentences | 9 |
| PubMedID- 22419301 | Human recombinant activated factor vii for upper gastrointestinal bleeding in patients with liver diseases. |
| PubMedID- 22514572 | It is administered promptly to all patients with active upper gastrointestinal bleeding and evidence of liver disease or portal hypertension until the source of bleeding can be determined by endoscopy. |
| PubMedID- 22972075 | Authors' conclusions: this updated review found no randomised clinical trials on the benefits and harms of vitamin k for upper gastrointestinal bleeding in patients with liver diseases. |
| PubMedID- 26058964 | Authors' conclusions: this updated review found no randomised clinical trials of vitamin k for upper gastrointestinal bleeding in people with liver diseases. |
| PubMedID- 22972089 | Therefore, antifibrinolytic amino acids have been proposed to be used as supplementary interventions alongside any of the primary treatments for upper gastrointestinal bleeding in patients with liver diseases. |
| PubMedID- 26201918 | Volume responsive is the most common type of aki due to frequent use of diuretics, large volume abdominal paracentesis and gastrointestinal bleeding in patients with liver disease. |
| PubMedID- 26058965 | Therefore, antifibrinolytic amino acids have been proposed to be used as supplementary interventions alongside any of the primary treatments for upper gastrointestinal bleeding in people with liver diseases. |
| PubMedID- 26528494 | The incidence of bacteremia was evaluated in upper gastrointestinal bleeding in patients with liver disease using endoscopic procedures in the emergency and elective settings. |
| PubMedID- 26265973 | Although scarcely reported in the literature, ecv should be considered a source of gastrointestinal bleeding, especially in a patient with liver disease. |
Page: 1